Skip to main content
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1982 Mar;45(3):253–256. doi: 10.1136/jnnp.45.3.253

CSF and plasma GABA levels in Parkinson's disease

RJ Abbott *, IF Pye *, SR Nahorski *
PMCID: PMC491347  PMID: 7086446

Abstract

CSF gamma-aminobutyric acid (GABA) levels were reduced in patients with idiopathic Parkinson's disease when compared with age matched controls, but the difference was not significant. However, when the Parkinsonian patients were subdivided, CSF GABA levels were lower in the levodopa treated group than in the untreated group and the controls. There was no difference in plasma GABA levels between Parkinsonian patients and controls.

Full text

PDF
253

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Böhlen P., Huot S., Palfreyman M. G. The relationship between GABA concentrations in brain and cerebrospinal fluid. Brain Res. 1979 May 11;167(2):297–305. doi: 10.1016/0006-8993(79)90824-2. [DOI] [PubMed] [Google Scholar]
  2. Grossman M. H., Hare T. A., Manyam N. V., Glaeser B. S., Wood J. H. Stability of GABA levels in CSF under various conditions of storage. Brain Res. 1980 Jan 20;182(1):99–106. doi: 10.1016/0006-8993(80)90833-1. [DOI] [PubMed] [Google Scholar]
  3. Iloyd K. G., Shemen L., Hornykiewicz O. Distribution of high affinity sodium-independent [3H]gamma-aminobutyric acid [3H]GABA binding in the human brain: alterations in Parkinson's disease. Brain Res. 1977 May 27;127(2):269–278. doi: 10.1016/0006-8993(77)90540-6. [DOI] [PubMed] [Google Scholar]
  4. Lakke J. P., Teelken A. W. Amino acid abnormalities in cerebrospinal fluid of patients with parkinsonism and extrapyramidal disorders. Neurology. 1976 May;26(5):489–493. doi: 10.1212/wnl.26.5.489. [DOI] [PubMed] [Google Scholar]
  5. Lees A. J., Shaw K. M., Stern G. M. Baclofen in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1978 Aug;41(8):707–708. doi: 10.1136/jnnp.41.8.707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. McGeer P. L., McGeer E. G., Wada J. A. Glutamic acid decarboxylase in Parkinson's disease and epilepsy. Neurology. 1971 Oct;21(10):1000–1007. doi: 10.1212/wnl.21.10.1000. [DOI] [PubMed] [Google Scholar]
  7. Price P. A., Parkes J. D., Marsden C. D. Sodium valproate in the treatment of levodopa-induced dyskinesia. J Neurol Neurosurg Psychiatry. 1978 Aug;41(8):702–706. doi: 10.1136/jnnp.41.8.702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Yoshida M., Precht W. Monosynaptic inhibition of neurons of the substantia nigra by caudato-nigral fibers. Brain Res. 1971 Sep 10;32(1):225–228. doi: 10.1016/0006-8993(71)90170-3. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES